nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—MPO—Carboplatin—esophageal cancer	0.322	0.427	CbGbCtD
Ticlopidine—MPO—Cisplatin—esophageal cancer	0.275	0.365	CbGbCtD
Ticlopidine—CYP2C9—Capecitabine—esophageal cancer	0.0641	0.085	CbGbCtD
Ticlopidine—CYP2B6—Cisplatin—esophageal cancer	0.0611	0.081	CbGbCtD
Ticlopidine—CYP2C9—Cisplatin—esophageal cancer	0.0323	0.0428	CbGbCtD
Ticlopidine—Diarrhoea haemorrhagic—Capecitabine—esophageal cancer	0.00318	0.0566	CcSEcCtD
Ticlopidine—Alveolitis allergic—Methotrexate—esophageal cancer	0.00229	0.0408	CcSEcCtD
Ticlopidine—Leukaemia—Methotrexate—esophageal cancer	0.00222	0.0395	CcSEcCtD
Ticlopidine—Clopidogrel—ABCB1—esophageal cancer	0.00153	1	CrCbGaD
Ticlopidine—Nephropathy—Methotrexate—esophageal cancer	0.00126	0.0224	CcSEcCtD
Ticlopidine—Bone marrow depression—Capecitabine—esophageal cancer	0.00119	0.0212	CcSEcCtD
Ticlopidine—Pain—Carboplatin—esophageal cancer	0.00113	0.0202	CcSEcCtD
Ticlopidine—Body temperature increased—Carboplatin—esophageal cancer	0.00105	0.0187	CcSEcCtD
Ticlopidine—Contusion—Capecitabine—esophageal cancer	0.00092	0.0164	CcSEcCtD
Ticlopidine—Bone marrow depression—Methotrexate—esophageal cancer	0.000885	0.0158	CcSEcCtD
Ticlopidine—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000876	0.0156	CcSEcCtD
Ticlopidine—Lung disorder—Methotrexate—esophageal cancer	0.000844	0.015	CcSEcCtD
Ticlopidine—Hyponatraemia—Cisplatin—esophageal cancer	0.000794	0.0141	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000791	0.0141	CcSEcCtD
Ticlopidine—Colitis—Capecitabine—esophageal cancer	0.000771	0.0137	CcSEcCtD
Ticlopidine—Ecchymosis—Capecitabine—esophageal cancer	0.000726	0.0129	CcSEcCtD
Ticlopidine—Cramp muscle—Cisplatin—esophageal cancer	0.000712	0.0127	CcSEcCtD
Ticlopidine—Sepsis—Capecitabine—esophageal cancer	0.000697	0.0124	CcSEcCtD
Ticlopidine—Diabetes mellitus—Capecitabine—esophageal cancer	0.00067	0.0119	CcSEcCtD
Ticlopidine—Vascular purpura—Capecitabine—esophageal cancer	0.000651	0.0116	CcSEcCtD
Ticlopidine—Pancytopenia—Cisplatin—esophageal cancer	0.000649	0.0116	CcSEcCtD
Ticlopidine—Hepatic failure—Capecitabine—esophageal cancer	0.000648	0.0115	CcSEcCtD
Ticlopidine—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000646	0.0115	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000618	0.011	CcSEcCtD
Ticlopidine—Vasculitis—Methotrexate—esophageal cancer	0.000612	0.0109	CcSEcCtD
Ticlopidine—Purpura—Capecitabine—esophageal cancer	0.000605	0.0108	CcSEcCtD
Ticlopidine—Renal failure—Cisplatin—esophageal cancer	0.000599	0.0107	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000597	0.0106	CcSEcCtD
Ticlopidine—Hyponatraemia—Capecitabine—esophageal cancer	0.000585	0.0104	CcSEcCtD
Ticlopidine—Osteoarthritis—Capecitabine—esophageal cancer	0.000583	0.0104	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000583	0.0104	CcSEcCtD
Ticlopidine—Ecchymosis—Methotrexate—esophageal cancer	0.00054	0.00962	CcSEcCtD
Ticlopidine—Liver function test abnormal—Capecitabine—esophageal cancer	0.000538	0.00958	CcSEcCtD
Ticlopidine—Sepsis—Methotrexate—esophageal cancer	0.000519	0.00924	CcSEcCtD
Ticlopidine—Tinnitus—Cisplatin—esophageal cancer	0.00051	0.00908	CcSEcCtD
Ticlopidine—Abdominal distension—Capecitabine—esophageal cancer	0.000507	0.00903	CcSEcCtD
Ticlopidine—Diabetes mellitus—Methotrexate—esophageal cancer	0.000499	0.00888	CcSEcCtD
Ticlopidine—Hepatic failure—Methotrexate—esophageal cancer	0.000483	0.0086	CcSEcCtD
Ticlopidine—Pancytopenia—Capecitabine—esophageal cancer	0.000478	0.00852	CcSEcCtD
Ticlopidine—Flatulence—Cisplatin—esophageal cancer	0.000469	0.00836	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00046	0.00819	CcSEcCtD
Ticlopidine—Muscle spasms—Cisplatin—esophageal cancer	0.000458	0.00815	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000445	0.00793	CcSEcCtD
Ticlopidine—Renal failure—Capecitabine—esophageal cancer	0.000441	0.00786	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00044	0.00784	CcSEcCtD
Ticlopidine—Osteoarthritis—Methotrexate—esophageal cancer	0.000434	0.00773	CcSEcCtD
Ticlopidine—Haematuria—Capecitabine—esophageal cancer	0.000428	0.00763	CcSEcCtD
Ticlopidine—Epistaxis—Capecitabine—esophageal cancer	0.000424	0.00754	CcSEcCtD
Ticlopidine—Myalgia—Cisplatin—esophageal cancer	0.000405	0.00722	CcSEcCtD
Ticlopidine—Haemoglobin—Capecitabine—esophageal cancer	0.000405	0.00722	CcSEcCtD
Ticlopidine—Haemorrhage—Capecitabine—esophageal cancer	0.000403	0.00718	CcSEcCtD
Ticlopidine—Hepatitis—Capecitabine—esophageal cancer	0.000403	0.00718	CcSEcCtD
Ticlopidine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000401	0.00713	CcSEcCtD
Ticlopidine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000389	0.00692	CcSEcCtD
Ticlopidine—Erythema multiforme—Capecitabine—esophageal cancer	0.000381	0.00679	CcSEcCtD
Ticlopidine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00038	0.00678	CcSEcCtD
Ticlopidine—Tinnitus—Capecitabine—esophageal cancer	0.000376	0.00669	CcSEcCtD
Ticlopidine—Eosinophilia—Methotrexate—esophageal cancer	0.000371	0.00661	CcSEcCtD
Ticlopidine—Anorexia—Cisplatin—esophageal cancer	0.00037	0.0066	CcSEcCtD
Ticlopidine—Pancytopenia—Methotrexate—esophageal cancer	0.000356	0.00634	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000354	0.0063	CcSEcCtD
Ticlopidine—Flatulence—Capecitabine—esophageal cancer	0.000346	0.00616	CcSEcCtD
Ticlopidine—Decreased appetite—Cisplatin—esophageal cancer	0.000338	0.00602	CcSEcCtD
Ticlopidine—Muscle spasms—Capecitabine—esophageal cancer	0.000337	0.00601	CcSEcCtD
Ticlopidine—Pain—Cisplatin—esophageal cancer	0.000332	0.00592	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000331	0.0059	CcSEcCtD
Ticlopidine—Renal failure—Methotrexate—esophageal cancer	0.000329	0.00585	CcSEcCtD
Ticlopidine—Haematuria—Methotrexate—esophageal cancer	0.000319	0.00568	CcSEcCtD
Ticlopidine—Epistaxis—Methotrexate—esophageal cancer	0.000315	0.00562	CcSEcCtD
Ticlopidine—Body temperature increased—Cisplatin—esophageal cancer	0.000307	0.00547	CcSEcCtD
Ticlopidine—Haemoglobin—Methotrexate—esophageal cancer	0.000302	0.00537	CcSEcCtD
Ticlopidine—Haemorrhage—Methotrexate—esophageal cancer	0.0003	0.00535	CcSEcCtD
Ticlopidine—Hepatitis—Methotrexate—esophageal cancer	0.0003	0.00535	CcSEcCtD
Ticlopidine—Myalgia—Capecitabine—esophageal cancer	0.000299	0.00532	CcSEcCtD
Ticlopidine—Arthralgia—Capecitabine—esophageal cancer	0.000299	0.00532	CcSEcCtD
Ticlopidine—Hypersensitivity—Cisplatin—esophageal cancer	0.000286	0.0051	CcSEcCtD
Ticlopidine—Erythema multiforme—Methotrexate—esophageal cancer	0.000284	0.00505	CcSEcCtD
Ticlopidine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00028	0.00499	CcSEcCtD
Ticlopidine—Tinnitus—Methotrexate—esophageal cancer	0.00028	0.00498	CcSEcCtD
Ticlopidine—Asthenia—Cisplatin—esophageal cancer	0.000279	0.00497	CcSEcCtD
Ticlopidine—Anorexia—Capecitabine—esophageal cancer	0.000273	0.00486	CcSEcCtD
Ticlopidine—Diarrhoea—Cisplatin—esophageal cancer	0.000266	0.00473	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000261	0.00465	CcSEcCtD
Ticlopidine—Dyspepsia—Capecitabine—esophageal cancer	0.000252	0.00449	CcSEcCtD
Ticlopidine—Decreased appetite—Capecitabine—esophageal cancer	0.000249	0.00443	CcSEcCtD
Ticlopidine—Vomiting—Cisplatin—esophageal cancer	0.000247	0.0044	CcSEcCtD
Ticlopidine—Rash—Cisplatin—esophageal cancer	0.000245	0.00436	CcSEcCtD
Ticlopidine—Pain—Capecitabine—esophageal cancer	0.000245	0.00436	CcSEcCtD
Ticlopidine—Dermatitis—Cisplatin—esophageal cancer	0.000245	0.00436	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000234	0.00417	CcSEcCtD
Ticlopidine—Nausea—Cisplatin—esophageal cancer	0.000231	0.00411	CcSEcCtD
Ticlopidine—Urticaria—Capecitabine—esophageal cancer	0.000228	0.00405	CcSEcCtD
Ticlopidine—Body temperature increased—Capecitabine—esophageal cancer	0.000226	0.00403	CcSEcCtD
Ticlopidine—Arthralgia—Methotrexate—esophageal cancer	0.000222	0.00396	CcSEcCtD
Ticlopidine—Myalgia—Methotrexate—esophageal cancer	0.000222	0.00396	CcSEcCtD
Ticlopidine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000213	0.0038	CcSEcCtD
Ticlopidine—Hypersensitivity—Capecitabine—esophageal cancer	0.000211	0.00376	CcSEcCtD
Ticlopidine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000209	0.00372	CcSEcCtD
Ticlopidine—Asthenia—Capecitabine—esophageal cancer	0.000206	0.00366	CcSEcCtD
Ticlopidine—Anorexia—Methotrexate—esophageal cancer	0.000203	0.00362	CcSEcCtD
Ticlopidine—Pruritus—Capecitabine—esophageal cancer	0.000203	0.00361	CcSEcCtD
Ticlopidine—Diarrhoea—Capecitabine—esophageal cancer	0.000196	0.00349	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000194	0.00346	CcSEcCtD
Ticlopidine—Dizziness—Capecitabine—esophageal cancer	0.000189	0.00337	CcSEcCtD
Ticlopidine—Dyspepsia—Methotrexate—esophageal cancer	0.000188	0.00334	CcSEcCtD
Ticlopidine—Decreased appetite—Methotrexate—esophageal cancer	0.000185	0.0033	CcSEcCtD
Ticlopidine—Pain—Methotrexate—esophageal cancer	0.000182	0.00325	CcSEcCtD
Ticlopidine—Vomiting—Capecitabine—esophageal cancer	0.000182	0.00324	CcSEcCtD
Ticlopidine—Rash—Capecitabine—esophageal cancer	0.000181	0.00322	CcSEcCtD
Ticlopidine—Dermatitis—Capecitabine—esophageal cancer	0.00018	0.00321	CcSEcCtD
Ticlopidine—Headache—Capecitabine—esophageal cancer	0.000179	0.0032	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000174	0.00311	CcSEcCtD
Ticlopidine—Nausea—Capecitabine—esophageal cancer	0.00017	0.00303	CcSEcCtD
Ticlopidine—Urticaria—Methotrexate—esophageal cancer	0.000169	0.00302	CcSEcCtD
Ticlopidine—Body temperature increased—Methotrexate—esophageal cancer	0.000169	0.003	CcSEcCtD
Ticlopidine—Hypersensitivity—Methotrexate—esophageal cancer	0.000157	0.0028	CcSEcCtD
Ticlopidine—Asthenia—Methotrexate—esophageal cancer	0.000153	0.00272	CcSEcCtD
Ticlopidine—Pruritus—Methotrexate—esophageal cancer	0.000151	0.00269	CcSEcCtD
Ticlopidine—Diarrhoea—Methotrexate—esophageal cancer	0.000146	0.0026	CcSEcCtD
Ticlopidine—Dizziness—Methotrexate—esophageal cancer	0.000141	0.00251	CcSEcCtD
Ticlopidine—Vomiting—Methotrexate—esophageal cancer	0.000136	0.00241	CcSEcCtD
Ticlopidine—Rash—Methotrexate—esophageal cancer	0.000134	0.00239	CcSEcCtD
Ticlopidine—Dermatitis—Methotrexate—esophageal cancer	0.000134	0.00239	CcSEcCtD
Ticlopidine—Headache—Methotrexate—esophageal cancer	0.000134	0.00238	CcSEcCtD
Ticlopidine—Nausea—Methotrexate—esophageal cancer	0.000127	0.00226	CcSEcCtD
Ticlopidine—CYP2E1—Metabolism—CRABP1—esophageal cancer	2.85e-05	0.000152	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ALOX15—esophageal cancer	2.82e-05	0.00015	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ALDOB—esophageal cancer	2.81e-05	0.00015	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ADH1B—esophageal cancer	2.78e-05	0.000148	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GNG7—esophageal cancer	2.76e-05	0.000147	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—NOS3—esophageal cancer	2.74e-05	0.000146	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GAPDH—esophageal cancer	2.71e-05	0.000144	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GNG7—esophageal cancer	2.71e-05	0.000144	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GSTO1—esophageal cancer	2.69e-05	0.000143	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—TPI1—esophageal cancer	2.69e-05	0.000143	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CRABP1—esophageal cancer	2.68e-05	0.000143	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CA2—esophageal cancer	2.65e-05	0.000141	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—TYMP—esophageal cancer	2.65e-05	0.000141	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.63e-05	0.00014	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.63e-05	0.00014	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—PIK3CA—esophageal cancer	2.61e-05	0.000139	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.59e-05	0.000138	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ALDH2—esophageal cancer	2.59e-05	0.000138	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.58e-05	0.000137	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ALDOB—esophageal cancer	2.58e-05	0.000137	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—ERBB2—esophageal cancer	2.57e-05	0.000137	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.55e-05	0.000136	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GNG7—esophageal cancer	2.55e-05	0.000136	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ALDH2—esophageal cancer	2.54e-05	0.000135	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.53e-05	0.000135	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.52e-05	0.000134	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GAPDH—esophageal cancer	2.48e-05	0.000132	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ADH7—esophageal cancer	2.47e-05	0.000131	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.47e-05	0.000131	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GSTT1—esophageal cancer	2.46e-05	0.000131	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CRABP1—esophageal cancer	2.46e-05	0.000131	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—TYMP—esophageal cancer	2.44e-05	0.00013	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.44e-05	0.00013	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP2A6—esophageal cancer	2.43e-05	0.00013	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—TYMP—esophageal cancer	2.42e-05	0.000129	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GSTT1—esophageal cancer	2.41e-05	0.000128	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—TPI1—esophageal cancer	2.4e-05	0.000128	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTO1—esophageal cancer	2.4e-05	0.000128	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ALDH2—esophageal cancer	2.39e-05	0.000127	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP2A6—esophageal cancer	2.38e-05	0.000127	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	2.37e-05	0.000126	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.35e-05	0.000125	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GNG7—esophageal cancer	2.34e-05	0.000125	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ALOX15—esophageal cancer	2.31e-05	0.000123	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTGS1—esophageal cancer	2.31e-05	0.000123	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ENO1—esophageal cancer	2.31e-05	0.000123	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ALDOB—esophageal cancer	2.3e-05	0.000123	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.29e-05	0.000122	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GSTT1—esophageal cancer	2.27e-05	0.000121	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PSME2—esophageal cancer	2.27e-05	0.000121	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PSME1—esophageal cancer	2.27e-05	0.000121	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCND1—esophageal cancer	2.27e-05	0.000121	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ENO1—esophageal cancer	2.26e-05	0.00012	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTGS1—esophageal cancer	2.26e-05	0.00012	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP2A6—esophageal cancer	2.25e-05	0.00012	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CA1—esophageal cancer	2.24e-05	0.000119	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.24e-05	0.000119	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.24e-05	0.000119	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PSME1—esophageal cancer	2.23e-05	0.000119	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PSME2—esophageal cancer	2.23e-05	0.000119	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GAPDH—esophageal cancer	2.22e-05	0.000118	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—TPI1—esophageal cancer	2.21e-05	0.000118	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTO1—esophageal cancer	2.21e-05	0.000118	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CRABP1—esophageal cancer	2.2e-05	0.000117	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ALDH2—esophageal cancer	2.19e-05	0.000117	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CDKN1A—esophageal cancer	2.19e-05	0.000117	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—TPI1—esophageal cancer	2.19e-05	0.000117	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.19e-05	0.000117	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ADH1B—esophageal cancer	2.16e-05	0.000115	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTGS1—esophageal cancer	2.13e-05	0.000113	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ENO1—esophageal cancer	2.13e-05	0.000113	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ALDOB—esophageal cancer	2.12e-05	0.000113	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PSME2—esophageal cancer	2.1e-05	0.000112	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PSME1—esophageal cancer	2.1e-05	0.000112	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.1e-05	0.000112	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GNG7—esophageal cancer	2.09e-05	0.000111	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—EP300—esophageal cancer	2.09e-05	0.000111	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GSTT1—esophageal cancer	2.09e-05	0.000111	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—TYMP—esophageal cancer	2.07e-05	0.00011	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	2.06e-05	0.00011	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.05e-05	0.000109	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CA2—esophageal cancer	2.05e-05	0.000109	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GAPDH—esophageal cancer	2.04e-05	0.000108	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.02e-05	0.000108	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CRABP1—esophageal cancer	2.02e-05	0.000108	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	2.01e-05	0.000107	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CRABP1—esophageal cancer	2e-05	0.000107	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP1B1—esophageal cancer	1.96e-05	0.000104	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.96e-05	0.000104	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.96e-05	0.000104	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ENO1—esophageal cancer	1.95e-05	0.000104	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.95e-05	0.000104	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PSME2—esophageal cancer	1.93e-05	0.000103	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PSME1—esophageal cancer	1.93e-05	0.000103	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP1B1—esophageal cancer	1.92e-05	0.000102	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GNG7—esophageal cancer	1.92e-05	0.000102	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ADH7—esophageal cancer	1.9e-05	0.000101	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.9e-05	0.000101	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GNG7—esophageal cancer	1.9e-05	0.000101	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—TPI1—esophageal cancer	1.87e-05	9.96e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.87e-05	9.96e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.86e-05	9.91e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP19A1—esophageal cancer	1.85e-05	9.82e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.84e-05	9.8e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.83e-05	9.77e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.83e-05	9.76e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MYC—esophageal cancer	1.82e-05	9.68e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP1B1—esophageal cancer	1.81e-05	9.65e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP19A1—esophageal cancer	1.81e-05	9.62e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.8e-05	9.58e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.79e-05	9.55e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.78e-05	9.5e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—EGFR—esophageal cancer	1.78e-05	9.47e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ENO1—esophageal cancer	1.74e-05	9.29e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.74e-05	9.29e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.73e-05	9.19e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PSME1—esophageal cancer	1.72e-05	9.15e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PSME2—esophageal cancer	1.72e-05	9.15e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.71e-05	9.12e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.71e-05	9.11e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP19A1—esophageal cancer	1.7e-05	9.07e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.7e-05	9.04e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.69e-05	9.01e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.68e-05	8.97e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.68e-05	8.95e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.68e-05	8.93e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.67e-05	8.9e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.67e-05	8.89e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.66e-05	8.85e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—HMOX1—esophageal cancer	1.65e-05	8.78e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GNG7—esophageal cancer	1.63e-05	8.66e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.62e-05	8.61e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.6e-05	8.54e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ENO1—esophageal cancer	1.6e-05	8.54e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TYMP—esophageal cancer	1.6e-05	8.5e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ENO1—esophageal cancer	1.59e-05	8.47e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.59e-05	8.47e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ABCB1—esophageal cancer	1.58e-05	8.43e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PSME2—esophageal cancer	1.58e-05	8.42e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PSME1—esophageal cancer	1.58e-05	8.42e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PSME1—esophageal cancer	1.57e-05	8.34e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PSME2—esophageal cancer	1.57e-05	8.34e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.56e-05	8.32e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—HMOX1—esophageal cancer	1.55e-05	8.28e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.55e-05	8.27e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CA—esophageal cancer	1.54e-05	8.22e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.53e-05	8.12e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.52e-05	8.12e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.51e-05	8.06e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.5e-05	7.99e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TP53—esophageal cancer	1.49e-05	7.95e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ABCB1—esophageal cancer	1.49e-05	7.95e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.48e-05	7.9e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.45e-05	7.72e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TPI1—esophageal cancer	1.44e-05	7.69e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.44e-05	7.69e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.43e-05	7.63e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.43e-05	7.6e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.43e-05	7.59e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.4e-05	7.45e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.39e-05	7.42e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.38e-05	7.37e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.37e-05	7.29e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.37e-05	7.29e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.36e-05	7.26e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ENO1—esophageal cancer	1.36e-05	7.24e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.36e-05	7.24e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.35e-05	7.2e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PSME1—esophageal cancer	1.34e-05	7.13e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PSME2—esophageal cancer	1.34e-05	7.13e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.33e-05	7.09e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.32e-05	7.03e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.28e-05	6.83e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.27e-05	6.77e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.27e-05	6.77e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GNG7—esophageal cancer	1.26e-05	6.69e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.25e-05	6.65e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.22e-05	6.5e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.18e-05	6.27e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.17e-05	6.23e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.17e-05	6.23e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.16e-05	6.18e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.16e-05	6.15e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.14e-05	6.06e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.13e-05	6.01e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.12e-05	5.98e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.12e-05	5.96e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.11e-05	5.93e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.11e-05	5.89e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.09e-05	5.78e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CREBBP—esophageal cancer	1.08e-05	5.75e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CREBBP—esophageal cancer	1.06e-05	5.63e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.05e-05	5.58e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.05e-05	5.58e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.03e-05	5.51e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.03e-05	5.5e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.03e-05	5.5e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CREBBP—esophageal cancer	9.97e-06	5.31e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—HMOX1—esophageal cancer	9.91e-06	5.28e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.73e-06	5.18e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—NOS3—esophageal cancer	9.67e-06	5.15e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ABCB1—esophageal cancer	9.52e-06	5.07e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—NOS3—esophageal cancer	9.47e-06	5.04e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.23e-06	4.92e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CREBBP—esophageal cancer	9.14e-06	4.87e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—NOS3—esophageal cancer	8.93e-06	4.75e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	8.92e-06	4.75e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTGS2—esophageal cancer	8.84e-06	4.71e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTGS2—esophageal cancer	8.66e-06	4.61e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.42e-06	4.48e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.38e-06	4.46e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—NOS3—esophageal cancer	8.19e-06	4.36e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTGS2—esophageal cancer	8.17e-06	4.35e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CREBBP—esophageal cancer	8.16e-06	4.35e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.65e-06	4.07e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CREBBP—esophageal cancer	7.51e-06	4e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTGS2—esophageal cancer	7.49e-06	3.99e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CREBBP—esophageal cancer	7.44e-06	3.96e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—EP300—esophageal cancer	7.36e-06	3.92e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.34e-06	3.91e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NOS3—esophageal cancer	7.31e-06	3.89e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—EP300—esophageal cancer	7.21e-06	3.84e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.19e-06	3.83e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—EP300—esophageal cancer	6.79e-06	3.62e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NOS3—esophageal cancer	6.72e-06	3.58e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTGS2—esophageal cancer	6.68e-06	3.56e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NOS3—esophageal cancer	6.66e-06	3.55e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CREBBP—esophageal cancer	6.36e-06	3.39e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—EP300—esophageal cancer	6.23e-06	3.32e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTGS2—esophageal cancer	6.15e-06	3.27e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTGS2—esophageal cancer	6.09e-06	3.24e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NOS3—esophageal cancer	5.69e-06	3.03e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—EP300—esophageal cancer	5.56e-06	2.96e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CA—esophageal cancer	5.44e-06	2.9e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CA—esophageal cancer	5.33e-06	2.84e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTGS2—esophageal cancer	5.21e-06	2.77e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—EP300—esophageal cancer	5.11e-06	2.72e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—EP300—esophageal cancer	5.07e-06	2.7e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CA—esophageal cancer	5.03e-06	2.68e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.91e-06	2.61e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	4.61e-06	2.45e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NOS3—esophageal cancer	4.39e-06	2.34e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—EP300—esophageal cancer	4.33e-06	2.31e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	4.11e-06	2.19e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.02e-06	2.14e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.78e-06	2.01e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.75e-06	2e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—EP300—esophageal cancer	3.34e-06	1.78e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.2e-06	1.71e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.47e-06	1.32e-05	CbGpPWpGaD
